Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile

The Lancet Oncology
V Duric, M Stockler

Abstract

Adjuvant chemotherapy for early breast cancer improves survival but is unpleasant and inconvenient. Women and clinicians need information about the magnitude of survival benefits considered sufficient to make the side-effects and inconvenience worthwhile. We sought studies that quantified the minimum required survival benefit by asking women who had experienced adjuvant chemotherapy. Four studies involving 512 women were appraised and summarised. All studies referred to chemotherapy given between 1980 and 1996, but the methods varied widely, especially the way in which women were recruited and questioned. However, the results were remarkably consistent. Most women said that small improvements in survival were sufficient to make adjuvant chemotherapy worthwhile. Women with dependants, social support, and milder side-effects judged smaller benefits worthwhile. Age, education, employment, and income status were not predictive of the women's responses. Optimum decision-making about the relative benefit of adjuvant chemotherapy requires up-to-date information from women receiving current chemotherapy and supportive regimens.

References

Feb 1, 1983·European Journal of Cancer & Clinical Oncology·A CoatesM H Tattersall
Feb 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M GriffinM H Tattersall
Feb 24, 2001·Journal of the National Cancer Institute·M E Lippman, D F Hayes

❮ Previous
Next ❯

Citations

Sep 28, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Martin PinquartUlrich Wedding
Nov 24, 2011·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Naoki NiikuraYutaka Tokuda
Apr 2, 2003·Urology·E David Crawford
Oct 3, 2003·Lancet·Michael Jefford, John Zalcberg
May 28, 2003·Patient Education and Counseling·Hanneke de Haes, Nelleke Koedoot
Jan 22, 2004·Critical Reviews in Oncology/hematology·Paula K Rauch, Anna C Muriel
Apr 14, 2006·The New England Journal of Medicine·Robert F OzolsRobert C Young
Jan 10, 2008·Journal of the National Cancer Institute·Prudence FrancisUNKNOWN BIG 02-98 Collaborative Group
Mar 2, 2005·Journal of Medical Ethics·T van Kleffens, E van Leeuwen
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeanne S MandelblattUNKNOWN Cancer Leukemia Group B
May 3, 2011·Journal of Oncology Practice·Elisabeth Edstrom ElderKatrina Moore
Jun 13, 2012·The Oncologist·Francesca Giorgi, Romeo Bascioni
Oct 3, 2014·Journal of Medical Internet Research·Moyez JiwaXingqiong Meng
Oct 6, 2010·Clinical Breast Cancer·Marie E WoodHyman B Muss
Sep 8, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Prunella BlinmanMartin R Stockler
Feb 9, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Prunella BlinmanMartin Stockler
Dec 26, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Weng NgMichael B Barton
Jul 17, 2009·Critical Reviews in Oncology/hematology·Martin Pinquart, Paul R Duberstein
Aug 6, 2013·Cancer·Steven J Katz, Monica Morrow
Sep 18, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W J LouwmanA C Voogd
Dec 1, 2010·Asia-Pacific Journal of Clinical Oncology·Stephen M KiharaPaul Crea
Mar 21, 2012·Head & Neck·Drew C BrotherstonJames R Wright
Oct 29, 2005·Journal of Psychosomatic Research·Karen L WeihsRobert S Siegel
Apr 9, 2005·Seminars in Oncology·Lidia Schapira
Aug 30, 2005·Journal of Psychosomatic Research·Louise SharpeStephen Clarke
Jun 24, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Prunella BlinmanMartin R Stockler
Jun 11, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Prunella BlinmanUNKNOWN Australasian Lung Cancer Trials Group (ALTG)
Feb 16, 2015·Critical Reviews in Oncology/hematology·Jean-Philippe SpanoAnthony Gonçalves
Dec 3, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·S A JacobV Do
Jul 30, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E HallUNKNOWN TACT Trial Investigators
Jul 6, 2014·Cancer Treatment Reviews·Victoria C HamelinckAnne M Stiggelbout
Oct 9, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Naomi IiharaYutaka Kirino
Apr 25, 2008·Patient Education and Counseling·Vlatka M DuricMartin R Stockler
Mar 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karin RibiGini F Fleming
Jul 23, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martine ExtermannJean-Pierre Droz
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvia J T JansenAnne M Stiggelbout
Aug 23, 2005·Social Science & Medicine·Louise Sharpe, Leah Curran
Nov 22, 2007·Expert Review of Anticancer Therapy·Peter S Grimison, Martin R Stockler
Jul 8, 2015·Cancers·Anna Rachelle Mislang, Laura Biganzoli
Jun 21, 2002·ANZ Journal of Surgery·Philip J Crowe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
V DuricR John Simes
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
M Baum, P M Ravdin
© 2022 Meta ULC. All rights reserved